These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 26882076)

  • 1. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
    Gomm W; von Holt K; Thomé F; Broich K; Maier W; Fink A; Doblhammer G; Haenisch B
    JAMA Neurol; 2016 Apr; 73(4):410-6. PubMed ID: 26882076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013.
    Park SK; Baek YH; Pratt N; Kalisch Ellett L; Shin JY
    Drug Saf; 2018 Jun; 41(6):615-624. PubMed ID: 29397553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
    Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
    Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
    Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
    Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
    Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
    PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of dementia in elderly patients with the use of proton pump inhibitors.
    Haenisch B; von Holt K; Wiese B; Prokein J; Lange C; Ernst A; Brettschneider C; König HH; Werle J; Weyerer S; Luppa M; Riedel-Heller SG; Fuchs A; Pentzek M; Weeg D; Bickel H; Broich K; Jessen F; Maier W; Scherer M
    Eur Arch Psychiatry Clin Neurosci; 2015 Aug; 265(5):419-28. PubMed ID: 25341874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emulating a target trial of proton pump inhibitors and dementia risk using claims data.
    Ahn N; Nolde M; Günter A; Güntner F; Gerlach R; Tauscher M; Amann U; Linseisen J; Meisinger C; Rückert-Eheberg IM; Baumeister SE
    Eur J Neurol; 2022 May; 29(5):1335-1343. PubMed ID: 35170158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study.
    Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K
    Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study.
    Mehta RS; Kochar B; Zhou Z; Broder JC; Chung P; Yang K; Lockery J; Fravel M; Ryan J; Mahady S; Orchard SG; McNeil JJ; Murray A; Woods RL; Ernst ME; Chan AT
    Gastroenterology; 2023 Sep; 165(3):564-572.e1. PubMed ID: 37315867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of death associated with the use of proton-pump inhibitors in patients with dementia and controls - a pharmacoepidemiological claims data analysis.
    Cetin H; Wurm R; Reichardt B; Tomschik M; Silvaieh S; Parvizi T; König T; Erber A; Schernhammer E; Stamm T; Stögmann E
    Eur J Neurol; 2020 Aug; 27(8):1422-1428. PubMed ID: 32281706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
    Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
    Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme-A plausible missing link for their association with incidence of dementia.
    Kumar R; Kumar A; Nordberg A; Långström B; Darreh-Shori T
    Alzheimers Dement; 2020 Jul; 16(7):1031-1042. PubMed ID: 32383816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.
    Gomm W; von Holt K; Thomé F; Broich K; Maier W; Weckbecker K; Fink A; Doblhammer G; Haenisch B
    J Alzheimers Dis; 2016 Sep; 54(2):801-8. PubMed ID: 27567804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nationwide Population-Based Cohort Study of Dementia Risk Among Acid Suppressant Users.
    Hwang IC; Chang J; Park SM
    Am J Geriatr Psychiatry; 2018 Nov; 26(11):1175-1183. PubMed ID: 30072307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.